<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The role of plasminogen activator inhibitor-1 (PAI-1) in the plasma, blood platelets, and vessel wall during <z:hpo ids='HP_0011009'>acute</z:hpo> arterial <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation was investigated in gene-deficient mice </plain></SENT>
<SENT sid="1" pm="."><plain>Photochemically induced <z:mp ids='MP_0005048'>thrombosis</z:mp> in the carotid artery was analyzed via transillumination </plain></SENT>
<SENT sid="2" pm="."><plain>In comparison to <z:mp ids='MP_0005048'>thrombosis</z:mp> in C57BL/6J <z:mp ids='MP_0002169'>wild-type</z:mp> (wt) mice (113 +/- 19 x 10(6) arbitrary light units [AU] n = 15, mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>), <z:mp ids='MP_0005048'>thrombosis</z:mp> in PAI-1(-/-) mice (40 +/- 10 x 10(6) AU, n = 13) was inhibited (P &lt;.01), indicating that PAI-1 controls fibrinolysis during <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation </plain></SENT>
<SENT sid="3" pm="."><plain>Systemic administration of murine PAI-1 into PAI-1(-/-) mice led to a full recovery of thrombotic response </plain></SENT>
<SENT sid="4" pm="."><plain>Occurrence of fibrinolytic activity was confirmed in alpha(2)-antiplasmin (alpha(2)-AP)-deficient mice </plain></SENT>
<SENT sid="5" pm="."><plain>The sizes of <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> developing in wt mice, in alpha(2)-AP(+/-) and alpha(2)-AP(-/-) mice were 102 +/- 35, 65 +/- 8.1, and 13 +/- 6.1 x 10(6) AU, respectively (n = 6 each) (P &lt;.05), compatible with functional plasmin inhibition by alpha(2)-AP </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> in wt mice, t-PA(-/-) and u-PA(-/-) mice were comparable, substantiating efficient inhibition of fibrinolysis by the combined PAI-1/alpha(2)-AP action </plain></SENT>
<SENT sid="7" pm="."><plain>Platelet <z:mpath ids='MPATH_63'>depletion</z:mpath> and reconstitution confirmed a <z:mpath ids='MPATH_458'>normal</z:mpath> thrombotic response in wt mice, reconstituted with PAI-1(-/-) platelets, but weak <z:mp ids='MP_0005048'>thrombosis</z:mp> in PAI-1(-/-) mice reconstituted with wt platelets </plain></SENT>
<SENT sid="8" pm="."><plain>Accordingly, murine (wt) PAI-1 levels in platelet lysates and releasates were 0.43 +/- 0.09 ng/10(9) platelets and plasma concentrations equaled 0.73 +/- 0.13 ng/mL </plain></SENT>
<SENT sid="9" pm="."><plain>After photochemical injury, plasma PAI-1 rose to 2.9 +/- 0.7 ng/mL (n = 9, P &lt;.01) </plain></SENT>
<SENT sid="10" pm="."><plain>The plasma rise was prevented by ligating the carotid artery </plain></SENT>
<SENT sid="11" pm="."><plain>Hence, during <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0005048'>thrombosis</z:mp>, fibrinolysis is efficiently prevented by plasma alpha(2)-AP, but also by vascular PAI-1, locally released into the circulation after endothelial injury </plain></SENT>
</text></document>